Under the administration of equal dose of cisplatin (5 mg/kg), the tumor growth of miR-124-overexpressed CD133+ HepG2 cells was obviously slower than the control CD133+ HepG2 tumors (Figure 7A). Here, PROM1 is linked to neoplasm.